Metropolitan Life Insurance Company (MetLife)’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,820
| Closed | -$21.6K | – | 1102 |
|
|
2024
Q1 | $21.6K | Hold |
1,820
| – | – | ﹤0.01% | 1818 |
|
|
2023
Q4 | $22.3K | Buy |
1,820
+467
| +35% | +$5.72K | ﹤0.01% | 1872 |
|
|
2023
Q3 | $13K | Hold |
1,353
| – | – | ﹤0.01% | 2094 |
|
|
2023
Q2 | $12.2K | Hold |
1,353
| – | – | ﹤0.01% | 2195 |
|
|
2023
Q1 | $10.6K | Sell |
1,353
-182
| -12% | -$1.43K | ﹤0.01% | 2134 |
|
|
2022
Q4 | $10.4K | Buy |
1,535
+161
| +12% | +$1.09K | ﹤0.01% | 2273 |
|
|
2022
Q3 | $19.9K | Hold |
1,374
| – | – | ﹤0.01% | 2030 |
|
|
2022
Q2 | $13.5K | Hold |
1,374
| – | – | ﹤0.01% | 2230 |
|
|
2022
Q1 | $20.3K | Sell |
1,374
-3,900
| -74% | -$57.5K | ﹤0.01% | 2089 |
|
|
2021
Q4 | $69.8K | Hold |
5,274
| – | – | ﹤0.01% | 2641 |
|
|
2021
Q3 | $92K | Buy |
5,274
+236
| +5% | +$4.12K | ﹤0.01% | 2568 |
|
|
2021
Q2 | $121K | Hold |
5,038
| – | – | ﹤0.01% | 2499 |
|
|
2021
Q1 | $129K | Buy |
5,038
+104
| +2% | +$2.67K | ﹤0.01% | 2306 |
|
|
2020
Q4 | $93.7K | Buy |
+4,934
| New | +$93.7K | ﹤0.01% | 2386 |
|
|
2019
Q3 | – | Sell |
-992
| Closed | -$22K | – | 2597 |
|
|
2019
Q2 | $22K | Buy |
+992
| New | +$22K | ﹤0.01% | 2594 |
|